The Ministry of Health has expanded the list of medicines subject to reimbursement under the Reimbursement Program for Medicines for Treatment of Cardiovascular Deceases, the Type 2 Diabetes (Noninsulin-Dependent) and Bronchial Asthma.
The Ministry of Health has said this in a statement, Ukrainian News Agency reports.
"The updated list of medicines subject to reimbursement enlists 199 drugs of 43 pharmaceutical companies, of which 21 companies are from the European Union, 17 - from Ukraine, four - from India and one from Israel," the statement said.
As Ukrainian News Agency earlier reported, the medicines reimbursement program took effect on April 1.
Who we are: About us, Contacts. How we write news and our principles: Editorial code. We did our best. If you found this valuable – please support us.
To request a correction, please send an email.